病菌
艰难梭菌
微生物学
毒力
菌群(微生物学)
抗生素
临床意义
腹泻
万古霉素
生物
人类病原体
梭菌
医学
细菌
金黄色葡萄球菌
病理
生物化学
遗传学
基因
作者
Kathryn E. Cherny,Emily Muscat,Megan E. Reyna,Larry K. Kociolek
出处
期刊:Anaerobe
[Elsevier BV]
日期:2021-07-28
卷期号:71: 102418-102418
被引量:38
标识
DOI:10.1016/j.anaerobe.2021.102418
摘要
Clostridium innocuum is an anaerobic, gram-positive, spore-forming bacterium identified by Smith and King in 1962 after being isolated from a patient with an appendiceal abscess. Its name, C. innocuum, reflected its clinically "innocuous" nature based on observed lack of virulence in animal models of infection. Since that time, C. innocuum has been identified as both part of the normal intestinal flora and the cause of a rare, intrinsically vancomycin-resistant opportunistic infection in immunocompromised patients. More recently, reports from Taiwan suggest that C. innocuum, in addition to being a known extraintestinal pathogen, may also be a diarrheal pathogen that causes a C. difficile infection-like antibiotic-associated diarrheal illness. However, unanswered questions about the clinical relevance of C. innocuum remain. Here we review the microbiological and clinical characteristics of this emerging pathogen.
科研通智能强力驱动
Strongly Powered by AbleSci AI